| Authors: |
Lee CYC; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom.; Cellular Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom., Dean I; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Richoz N; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom., Li Z; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Kennedy BC; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; NDM Centre for Immuno-Oncology, University of Oxford, Oxford, United Kingdom., Vettore LA; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; NDM Centre for Immuno-Oncology, University of Oxford, Oxford, United Kingdom., Samarakoon Y; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom., Gilroy KL; Cancer Research UK Scotland Institute, Glasgow, United Kingdom., Hasegawa T; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom., Carlesso G; Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Hammond SA; Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Dovedi SJ; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Sansom OJ; Cancer Research UK Scotland Institute, Glasgow, United Kingdom., Tuong ZK; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom.; Cellular Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom., Halim TYF; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom., Withers DR; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; NDM Centre for Immuno-Oncology, University of Oxford, Oxford, United Kingdom., Clatworthy MR; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom.; Cellular Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom. |
